as 07-26-2024 4:00pm EST
Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Upcoming Earnings Alert:
Get ready for potential market movements as Bausch + Lomb Corporation BLCO prepares to release earnings report on 31 Jul 2024.
Founded: | 1853 | Country: | Canada |
Employees: | N/A | City: | VAUGHAN |
Market Cap: | 5.9B | IPO Year: | 2022 |
Target Price: | $18.44 | AVG Volume (30 days): | 738.1K |
Analyst Decision: | Buy | Number of Analysts: | 9 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.96 | EPS Growth: | N/A |
52 Week Low/High: | $13.16 - $20.30 | Next Earning Date: | 07-31-2024 |
Revenue: | $4,314,000,000 | Revenue Growth: | 13.23% |
Revenue Growth (this year): | 14.57% | Revenue Growth (next year): | 5.73% |
BLCO Breaking Stock News: Dive into BLCO Ticker-Specific Updates for Smart Investing
Morningstar Research
a day ago
Morningstar Research
2 days ago
Morningstar Research
9 days ago
Business Wire
15 days ago
Business Wire
19 days ago
Business Wire
a month ago
Business Wire
2 months ago
Business Insider
2 months ago
The information presented on this page, "BLCO Bausch + Lomb Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.